CTOs on the Move

CCA Industries

www.ccaindustries.com

 
CCA Industries, Inc. (CCA) is engaged in the health and beauty aids business, selling numerous products in several health and beauty aids and cosmeceutical categories.
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

PG Drives Technology

PG Drives Technology is a Anaheim, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mediture

Mediture is a Eden Prairie, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VandP Scientific

V&P Scientific is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Pfizer

Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. We make medicines and vaccines that help people when they are sick and prevent them from getting sick in the first place, as well as some of the world`s best-known consumer healthcare brands. Every day, our colleagues work in developed and emerging markets to treat, cure and eradicate life-threatening conditions and challenge some of the most feared diseases of our time. Pfizer also collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

SetPoint Medical

SetPoint Medical is developing novel neuromodulation therapies to treat those who suffer from inflammatory diseases such as Crohn`s Disease and rheumatoid arthritis. The company is developing a proprietary and innovative neuromodulation therapy delivery platform consisting of a micro-regulator programmed via a unique prescription pad based interface. This novel therapy will provide patients and healthcare providers with a safe and efficacious alternative to drugs, while costing payors less than 50% of what today`s leading biologic therapies cost.